<DOC>
	<DOCNO>NCT01864031</DOCNO>
	<brief_summary>The association alcohol consumption cardiovascular disease ( CVD ) mostly examine use broad endpoint cause-specific mortality . The purpose study compare effect alcohol consumption aetiology range cardiovascular disease phenotype .</brief_summary>
	<brief_title>The Role Alcohol Consumption Aetiology Different Cardiovascular Disease Phenotypes : CALIBER Study</brief_title>
	<detailed_description>The relationship cardiovascular disease ( CVDs ) alcohol consumption complex . Moderate alcohol consumption consistently find associate reduce risk commonly report aggregate CVD ( e.g . coronary heart disease [ CHD ] ) heavy drinking ( abstain alcohol ) believe associate augmented risk . However , much remain clarified . For example , previous study typically small size adequately assess impact alcohol consumption range major , pathologically distinct CVDs . Understanding role alcohol consumption specific CVDs may provide novel insight mechanism give rise observe beneficial effect moderate consumption aggregate . As focus research question effect alcohol consumption specific cardiovascular phenotype derive single primary outcome . Utilising strengths CALIBER data platform define multiple cardiovascular disease outcome include : chronic stable angina ( SA ) , unstable angina ( UA ) , coronary heart disease otherwise specify ( CHD , NOS ) , acute myocardial infarction ( MI ) , heart failure ( HF ) , ventricular arrhythmia include cardiac arrest , abdominal aortic aneurysm ( AAA ) , peripheral arterial disease ( PAD ) , ischaemic haemorrhagic ( subarachnoid intracerebral ) stroke , transient ischaemic attack ( TIA ) , sudden cardiac death ( SCD ) unheralded coronary death ( UCD ) . Additionally non-CVD mortality define compete outcome . These outcome defined/validated use multiple source ; include combination symptom , diagnosis ( include use additional information ECG find troponin value ) prescription . For comparison purpose ( major studies/existing consortium ) also estimate model aggregate CHD ( MI unheralded coronary death ) , CVD ( CHD stroke type ) fatal CVD ( combination fatal CHD fatal CVD ) endpoint . Secondary outcome : To examine whether association drinking category specific MI phenotype differ rerun model patient remain cohort January 2003 , information MINAP become available . This allow composite MI category decompose ST elevation myocardial infarction ( STEMI ) , non-ST elevation myocardial infarction ( nSTEMI ) myocardial infarction otherwise specify ( MI NOS ) . In light current debate U/J-shaped relationship observe alcohol consumption aggregate CVD outcome five drink category define include : ( 1 ) Never drinker ( `` tee-total '' `` non-drinkers '' ) , former drinker ( code `` stop drink alcohol '' and/or `` ex-drinker '' ) , occasional drinker ( code `` drink rarely '' and/or `` drink occasionally '' ) , current moderate drinker ( code current alcohol consumer indicator whether drank within daily [ 4/3 UK unit alcohol men woman respectively ] weekly [ 21/14 UK unit men woman respectively ] recommend sensible drinking limit ) current heavy drinker ( define exceed daily weekly sensible drink limit ) . Unfortunately information binge drinking available select minority cohort ( ~100 people ) therefore separate category drink behaviour define ( patient cod heavy drinker ) . Our referent category current moderate drinker . Competing-risk Cox proportional hazard model use examine association drink category different cardiovascular disease phenotype . Competing-risk regression take account instantaneous failure rate specific competing-causes ( i.e . different cardiovascular phenotype death non-coronary cause ) - may overestimate association drink category outcome . A detailed analytic protocol available upon request . This study part CALIBER ( Cardiovascular disease research use link bespoke study electronic record ) programme fund 5 year NIHR Wellcome Trust . The central theme CALIBER research linkage Myocardial Ischaemia National Audit Project ( MINAP ) primary care ( GPRD ) , secondary care ( HES ) resource . The overarch aim CALIBER good understand aetiology prognosis specific coronary phenotype across range causal domain , particularly electronic record provide contribution beyond traditional study . CALIBER receive Ethics approval ( ref 09/H0810/16 ) ECC approval ( ref ECC 2-06 ( b ) /2009 CALIBER dataset ) .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Death</mesh_term>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<mesh_term>Death , Sudden , Cardiac</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Intracranial Hemorrhages</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>Aged â‰¥ 30 year . Patient GPRD register practice consent linkage process ( also meet data quality standard ) . A recorded history cardiovascular disease phenotype prior enter study . Cause death unknown .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Alcohol</keyword>
	<keyword>Drinking</keyword>
	<keyword>Abstainers</keyword>
	<keyword>Former drinker</keyword>
	<keyword>Ex-drinkers</keyword>
	<keyword>Aetiology</keyword>
	<keyword>Initial presentation</keyword>
	<keyword>Chronic Stable Angina</keyword>
	<keyword>Unstable Angina</keyword>
	<keyword>Coronary Heart Disease Not Otherwise Specified</keyword>
	<keyword>Acute Myocardial Infarction</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>ST elevation Myocardial Infarction ( STEMI )</keyword>
	<keyword>non-ST elevation Myocardial Infarction ( nSTEMI )</keyword>
	<keyword>Myocardial Infarction Not Otherwise Specified ( MI NOS )</keyword>
	<keyword>Ventricular Arrhythmias</keyword>
	<keyword>Cardiac Arrest</keyword>
	<keyword>Abdominal Aortic Aneurysm</keyword>
	<keyword>Peripheral Arterial Disease</keyword>
	<keyword>Ischaemic Stroke</keyword>
	<keyword>Subarachnoid Haemorrhagic Stroke</keyword>
	<keyword>Intracerebral haemorrhagic Stroke</keyword>
	<keyword>Stroke Not Otherwise Specified</keyword>
	<keyword>Sudden Cardiac Death</keyword>
	<keyword>Unheralded Coronary Death</keyword>
	<keyword>Mortality</keyword>
	<keyword>Coronary Heart Disease ( CHD )</keyword>
	<keyword>Cardiovascular Disease ( CVD )</keyword>
	<keyword>Fatal Cardiovascular Disease ( fatal CVD )</keyword>
</DOC>